| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $3,576,461 ) |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R00NS116129 | The Role of Sensory Inputs and Cholinergic Modulation for the Coding of Location and Movement Speed in the Entorhinal Cortex | 000 | 5 | NIH | 2/28/2024 | $351,624 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH134389 | Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain | 000 | 2 | NIH | 4/29/2024 | $308,649 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AG085616 | SCH: Novel and Interpretable Statistical Learning for Brain Images in AD/ADRDs | 000 | 2 | NIH | 4/17/2024 | $276,364 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R03ES035536 | Impact of Exposure to Perfluoroalkyl Substances on Weight Loss: A Pilot Study of Hispanic Children with Overweight/Obesity Participating in aCommunity-based Weight Loss Intervention Program | 000 | 1 | NIH | 1/11/2024 | $103,670 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH132552 | Paid Sick Leave Mandates and Mental Healthcare Service Use | 000 | 2 | NIH | 2/7/2024 | $473,754 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R00NS116129 | The Role of Sensory Inputs and Cholinergic Modulation for the Coding of Location and Movement Speed in the Entorhinal Cortex | 001 | 5 | NIH | 4/9/2024 | $27,350 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH134389 | Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain | 000 | 2 | NIH | 4/29/2024 | $293,694 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | K01MD016346 | A community-based intervention to increase PrEP initiation among Black sexual minority men in Prince George's County, Maryland: Reducing internalized stigma and increasing social support | 000 | 4 | NIH | 12/6/2023 | $110,523 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AI148012 | Mechanisms of PSGL-1 restriction of HIV virion infectivity | 000 | 5 | NIH | 4/1/2024 | $385,591 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01ES031079 | Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) Study | 000 | 5 | NIH | 11/17/2023 | $257,562 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | U01EB027601 | Sonomyographic Upper Limb Prosthetics: A New Paradigm | 000 | 5 | NIH | 3/13/2024 | $636,417 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01NS039600 | Generation and Description of Neuronal Morphology and Connectivity | 000 | 24 | NIH | 3/27/2024 | $332,055 |
| 2024 | 2024 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01NS039600 | Generation and Description of Neuronal Morphology and Connectivity | 001 | 24 | NIH | 4/9/2024 | $25,827 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | CE152729 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/8/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | CE152729 | Community Project Funding/Congressionally Directed Spending - Construction | 02 | 1 | HRSA | 11/16/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | H79FG000942 | Saving Young Lives and Decreasing Health Disparities Through the Dissemination of Culturally Sensitive Evidence-Based Assessments to State-Funded Behavioral Health Organizations | 000 | 1 | SAMHSA | 11/17/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | K02DA058840 | Integrating neural and momentary assessment of parenting, arousal, and adolescent substance use | 000 | 1 | NIH | 10/13/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220109 | Detecting and Addressing Bulimia Nervosa in Adolescent Girls through Local Community Service Boards | 01 | 2 | DHHS/OS | 12/8/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220114 | SurrEndo NoVA:Integrating a technology based serious gaming intervention to clinical screening to address endometriosis in adolescence | 01 | 2 | DHHS/OS | 12/5/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01DA056113 | Estradiol signaling pathways mediating sex differences in striatal synaptic plasticity | 000 | 1 | NIH | 2/20/2024 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AG069352 | Resource Use and Quality of Care in Medicare Advantage | 001 | 4 | NIH | 4/30/2024 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AG069352 | Resource Use and Quality of Care in Medicare Advantage | 000 | 4 | NIH | 3/25/2024 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | U2CDA050097 | JCOIN Coordination and Translation Center | 001 | 5 | NIH | 3/20/2024 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | U2CDA050097 | JCOIN Coordination and Translation Center | 000 | 5 | NIH | 10/23/2023 | $0 |
| 2024 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01DA033431 | Parent-adolescent interactions, gender, and substance use: Brain mechanisms. | 000 | 10 | NIH | 3/6/2024 | $0 |
| 2024 | 2022 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220109 | Detecting and Addressing Bulimia Nervosa in Adolescent Girls through Local Community Service Boards | 01 | 2 | DHHS/OS | 12/8/2023 | $0 |
| 2024 | 2022 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220114 | SurrEndo NoVA:Integrating a technology based serious gaming intervention to clinical screening to address endometriosis in adolescence | 01 | 2 | DHHS/OS | 12/5/2023 | $0 |
| 2024 | 2022 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R13TR004288 | American Society for Intercellular Communication (ASIC) | 000 | 1 | NIH | 2/16/2024 | -$410 |
| 2024 | 2022 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R13TR004288 | American Society for Intercellular Communication (ASIC) | 000 | 1 | NIH | 2/16/2024 | -$1,638 |
| 2024 | 2022 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | G20AI167408 | Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) | 001 | 1 | NIH | 2/2/2024 | $0 |
| 2024 | 2021 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | G20AI167408 | Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) | 000 | 1 | NIH | 2/2/2024 | $0 |
| 2024 | 2021 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R21DA050176 | Effect on CBD on Exosome release from CNS infected cells | 000 | 2 | NIH | 3/11/2024 | -$17 |
| 2024 | 2020 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R21HD097472 | Bridging adult to pediatric markers of tuberculosis disease severity | 000 | 2 | NIH | 12/5/2023 | -$4,553 |
| 2024 | 2020 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01NS099029 | HIV neuropathogenesis related to exosomes containing HIV non-coding RNAs | 000 | 5 | NIH | 11/29/2023 | -$1 |
|
| Issue Date FY: 2023 ( Subtotal = $23,219,731 ) (Continued on the next page) |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH134389 | Cell-derived extracellular vesicle mediated epigenetic silencing of HIV in the brain | 000 | 1 | NIH | 8/2/2023 | $322,720 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R21CA251015 | New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions | 000 | 3 | NIH | 3/31/2023 | $161,325 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01ES031079 | Investigating Mixtures of Pollutants and Endometriosis in Tissue (IMPLANT) Study | 000 | 4 | NIH | 12/2/2022 | $256,085 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | K02DA058840 | Integrating neural and momentary assessment of parenting, arousal, and adolescent substance use | 000 | 1 | NIH | 6/30/2023 | $125,166 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220109 | Detecting and Addressing Bulimia Nervosa in Adolescent Girls through Local Community Service Boards | 00 | 2 | DHHS/OS | 9/21/2023 | $441,489 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | ASTWH220114 | SurrEndo NoVA:Integrating a technology based serious gaming intervention to clinical screening to address endometriosis in adolescence | 00 | 2 | DHHS/OS | 9/21/2023 | $241,751 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH132552 | Paid Sick Leave Mandates and Mental Healthcare Service Use | 000 | 1 | NIH | 3/14/2023 | $641,155 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R21CA284201 | Secretory Mitophagy in Cancer Metabolic Reprogramming | 000 | 1 | NIH | 7/11/2023 | $204,502 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R21EY032152 | Secondary Analyses of data from the Infant Aphakia Treatment Study: Patching in Children with Unilateral Congenital Cataracts and Poor Visual Acuity | 000 | 2 | NIH | 1/27/2023 | $231,164 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | OT2OD034479 | HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance Uptake | 003 | 1 | NIH | 8/31/2023 | $2,953,243 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AG069352 | Resource Use and Quality of Care in Medicare Advantage | 001 | 4 | NIH | 5/22/2023 | $639,264 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AG069352 | Resource Use and Quality of Care in Medicare Advantage | 000 | 3 | NIH | 3/15/2023 | $422,086 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01AI143817 | Developing capsid-importin alpha inhibitors for the treatment of VEEV infection | 000 | 4 | NIH | 8/18/2023 | $679,799 |
| 2023 | 2023 | GEORGE MASON UNIVERSITY | 4400 UNIVERSITY DR | FAIRFAX | VA | 22030-4422 | FAIRFAX CITY | USA | R01MH118680 | Evaluation of Stepping Up Efforts to Improve MH Services and Justice Utilization | 000 | 5 | NIH | 7/26/2023 | $617,754 |
|